Delivery Order SPE2DE23D0008-SPE2D625F8KZ1
- Not listed
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a delivery order valued at $2,814.00 by the Defense Logistics Agency's Medical Supply Chain division on July 22, 2025, with an ultimate completion date of July 24, 2025. The contract covers the supply of Natrelle Inspira SCM 375CC breast implants and will be performed in Irvine, California. This award was made without set-aside designation, reflecting Allergan's position as a specialized supplier of these medical devices to federal...
- Allergan USA Inc., a subsidiary of AbbVie Inc., has been awarded a delivery order valued at $1,425.00 for Natrelle Inspira SCM 560CC breast implants by the Defense Logistics Agency Medical Supply Chain, a Defense agency division. The award, issued on August 14, 2025, represents a fixed-price contract with economic price adjustment provisions and carries an ultimate completion date of August 18, 2025. The contract was awarded without set-aside designation, reflecting Allergan's status as a...
- Allergan USA Inc., a subsidiary of AbbVie Inc., has been awarded a $1,200 fixed-price delivery order by the Defense Logistics Agency (DLA) Medical Supply Chain for Natrelle Inspira SSF 325CC breast implants. This delivery order, awarded on July 24, 2025, with an ultimate completion date of July 28, 2025, represents a child contract under one of Allergan's larger Indefinite Delivery Vehicle (IDV) agreements. The contract does not utilize a set-aside designation, reflecting Allergan's position...
- Allergan USA Inc., a subsidiary of AbbVie Inc., has been awarded a fixed-price delivery order valued at $3,021.00 for Natrelle Inspira SCLP 300cc breast implants from the Defense Logistics Agency's Medical Supply Chain division. This delivery order, which carries no set-aside designation, was awarded on August 14, 2025, with an ultimate completion date of August 18, 2025, and will be performed at Allergan's facility in Irvine, California. The award reflects Allergan's status as a sole-source...
- The Defense Logistics Agency's Medical Supply Chain division awarded Allergan USA Inc. a $2,814.00 fixed-price delivery order for Natrelle Inspira SCF 365CC breast implants with an ultimate completion date of August 22, 2025. This delivery order, issued on July 30, 2025, represents a child contract under one of Allergan's larger Indefinite Delivery Vehicle contracts valued at $13.5 million for Natrelle breast implants and surgical devices established in December 2022. The contract does not...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,990 fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain division on July 10, 2025, for Natrelle TE Smooth 133S breast implants. This delivery order, which carries an ultimate completion date of July 28, 2025, represents a child award under one of Allergan's two significant Indefinite Delivery Vehicle contracts established with DLA Troop Support Medical on December 8, 2022. The award was made without...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a $2,850.00 fixed-price delivery order contract to Allergan USA Inc., a subsidiary of AbbVie Inc., for the supply of 240cc NATRELLE INSPIRA SSM breast implants. This contract has an ultimate completion date of May 28, 2024 and does not utilize any set-aside designations. Allergan is a leading provider of medical devices and pharmaceutical products to federal agencies, including the Department of Defense, Department of Veterans...
- The Defense Logistics Agency's Medical Supply Chain division awarded a $2,607 fixed-price delivery order with economic price adjustment to Allergan USA Inc. for Natrelle Inspira SCF 295CC breast implants, with an ultimate completion date of August 13, 2025. This delivery order represents a child contract under Allergan's larger $13.5 million Indefinite Delivery Vehicle for Natrelle breast implants and surgical devices established on December 8, 2022. The award carries no set-aside designation,...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a fixed-price delivery order valued at $3,404.00 for Natrelle TE Smooth 133S-MX-14-T breast implants on July 24, 2025. This delivery order, issued without set-aside designation, represents a child contract under Allergan's larger Indefinite Delivery Vehicle (IDV) agreements with the Defense Logistics Agency (DLA) Troop Support Medical. The contract is funded through the Medical Supply Chain division of DLA and involves fixed-price...
- This federal contract award is for the delivery of Natrelle Inspira SCF 385CC breast implants to the U.S. government. The $2,607.00 fixed-price delivery order was awarded to Allergan USA Inc., a subsidiary of AbbVie Inc., by the Defense Logistics Agency Troop Support Medical. The contract has an ultimate completion date of July 2, 2025 and does not utilize a set-aside designation. Allergan USA Inc. is a leading medical device and pharmaceutical company that specializes in the production of...
- SPE2DE23D0008Indefinite Delivery Contract
- SPE2DE23D0008-SPE2D625F8KZ1Delivery Order
Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a delivery order valued at $2,814.00 by the Medical Supply Chain division of the Defense Logistics Agency on July 24, 2025, for Natrelle Inspira SSM 445CC breast implants. This fixed-price delivery order with economic price adjustment represents a child award issued without set-aside designation, reflecting Allergan's status as a sole-source provider of specialized surgical implants to the federal government. The order is scheduled for completion by July 28, 2025, with performance taking place at Allergan's facility in Irvine, California. This delivery order derives from one of two significant Indefinite Delivery Vehicles established between Allergan USA Inc. and Defense Logistics Agency Troop Support Medical on December 8, 2022—specifically the $13.5 million IDV for Natrelle breast implants and surgical devices. The underlying IDV structure enables the electronic ordering and fulfillment of Allergan's products across Department of Defense research centers, hospitals, and clinics, supporting reconstructive and aesthetic surgical procedures for military members, veterans, and eligible beneficiaries. Allergan's federal contracts consistently feature fixed-price structures with economic price adjustment provisions, ensuring cost stability while accommodating market fluctuations for these critical medical technologies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 7/24/25 |